The Anti-Cancer Profile Of Co-enzyme Q10

638 views

You might know Coenzyme Q10 as an ingredient in your favorite anti-aging lotions and potions, but did you know it’s also being used as a homeopathic cancer cure? Read on to find out what gives CoQ10 its anti-cancer reputation among naturopaths. CoQ10 (Ubiquinone) is a naturally produced substance similar to Vitamin E that has significant anti-oxidant properties. Of the 10 most common Coenzyme Q’s, CoQ10 is the only Coenzyme Q present in human cellular tissue. Due to the natural effects of aging, CoQ10 levels significantly decrease with maturity. For example, at 40 years of age, we have only 64% of the CoQ10 originally present at age 20. By age 80, this figure drops by half to 36% of the CoQ10 we had at 20 years of age. CoQ10, being a cellular component (Quinone), is a cyclic compound present in all human cells.

Consuming cooked or processed foods destroy CoQ10, including the very substrates employed to manufacture and replace CoQ10 stores. In its active form, pure CoQ10 is bright yellow. Though once it is subjected to light or 115 degrees Fahrenheit, it will unfortunately degenerate into an inactive and unusable state. To reduce an excessive amount of CoQ10 tissue loss, it is highly recommended to consume wholesome, non-processed foods rich in CoQ10. Some examples to begin with are uncooked nuts, sardines, cereals, and green vegetables.

Contemporary research findings clearly indicate consistent oral intake of COQ-10 enhances daily peak performance and robust health. The New England Institute evidently states COQ-10 has the ideal potency to reduce mortality from tumors and leukemia in animal experiments.

CoQ10 supplementation has been repeatedly substantiated in past research projects. In addition to being recently proven against AIDS, other ailments are alleviated. These ailments include cancer, multiple sclerosis, candidiasis, allergies, diabetes, asthma, obesity, respiratory disease, schizophrenia, Alzheimer’s disease, and periodontal disease.

Studies have reaffirmed that low levels of CoQ10 directly contribute to the speeding up of our oft-resented and inevitable aging process. Increasing CoQ10 supplementation will positively lessen the natural aging process so many of us yearn to hinder. CoQ10 absolutely reduces the risk of heart attacks, increases heart muscle efficiency, lowers high blood pressure, and enforces immunity. Judging by abundant and emphatic testimonials, Exsula Iridesca successfully mitigates a majority of these maladies. CoQ10 is especially recommended in our LEC programs to delay the onset of irreversible aging.

Our bodies do not have the capability to fabricate energy without Q10. Shortly after age 20, an individual’s liver output of Q10 declines to sub-par health levels. From the age of 40, substantial decline manifests itself in many guises. These include increased fat levels, a noticeable lack of physical ambition, downgraded daily work efficiency, lessened sexual vigor and frequency. This extensive pattern of deteriorating health ultimately culminates in gum disease. In terms of importance, Q10 is most vital to a person’s heart, followed by one’s immune system.

Quite interestingly, the liver necessitates the presence of Q10 to produce optimal levels of Q10, amidst other enzymes. Without proper amounts of Q10, enzymatic production is severely degraded. This much maligned condition is indicated by premature aging, constricted day-to-day mobility, and aggravated senility.

Previously considered the fountain of youth, Q10 essentially provides the spark of life to persistently maintain robust, healthy, and irreplaceable cells. Mitochondria, the energy generators within cells, harbor Q10 in order to combat the destructive effects of metabolic byproducts as a result of energy manufacturing. This must occur to prevent irreparable long-term damage to the delicate mitochondria itself.

Landmark Breast Cancer Study – Copenhagen

Dr. Karl Folkers of Merck Laboratories, charted the first trial of Co-Q10 in Copenhagen, Denmark, in late 1993.Thirty-two patients were treated for advanced, “high risk” cancer of the breast. Each patient was administered daily dosages of 90 mg of CoQ10. This dosage was complemented by necessary surgical procedures and prevailing treatments of the day. These patients also received carefully measured dosages of minerals, vitamins, antioxidants, and fatty acids. As a result, six of the patients from the original 32 exhibited partial tumor regressions. Given the circumstances, such welcomed regressions were obviously considered significant progress in late stage patients.

In October 1993, a patient with tumor regression acted independently of Dr. Folkers’ clinical trial, and decided to increase her CoQ10 intake from 90 mg to 390 mg per day. The following month, this woman’s doctors noted her regressed tumor was rendered completely non-palpable. The month after, a mammogram did in fact verify the tumor was indeed vanquished. Based on this, a second patient from the same experiment followed suite, and also incremented her dosage, albeit to a lesser extent. She only raised her CoQ10 to 300mg. In short order, her tumor was also thoroughly eliminated. Clinical analysis later resulted in no former existence of any such residual tumor. This included no indication whatsoever of distant metastases.

To Sum it All Up

In westernized nations, CoQ remains frustratingly uncommon, despite being first discovered in the USA nearly forty years prior. CoQ10 is one of the most widely deployed drugs in Japan, a country where the greatest majority of clinical research has been conducted. In 1963, on a case-by-case basis, Japan initiated human testing. From 1974, clinical trials could finally be meted out, thankfully due to sufficient supplies of pure CoQ10 becoming much easier to obtain. The United States and other western countries have not implemented popular use of Co-Q10 due to profit limitations. CoQ10 is a naturally occurring substance, so patents are not at all possible. As a result, profit margins have remained disappointingly low. In addition, profits from competitive patented drugs with like results were overshadowed by the proven effectiveness of CoQ10. Recently, the FDA has been unsuccessful in their attempts to eliminate CoQ10 from health food businesses.